Eli Lilly and Company · 1 day ago
Senior Director, Competitive Insights and Strategy
Indianapolis, IN
Full-time
Onsite
Director/Executive
$170K/yr - $249K/yr
10+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, dedicated to discovering and delivering life-changing medicines. The Senior Director, Competitive Insights and Strategy will provide critical strategic insights to inform pipeline decisions and shape the future of the company's portfolio by integrating complex scientific, technical, business, and market information.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Serve as the expert on external drug discovery and development platforms and technologies, anticipating competitive shifts to guide strategic priorities and decisions
Conduct comprehensive company and industry pipeline analyses, both within and outside Lilly's current therapeutic areas, to identify opportunities, assess risks, and guide portfolio prioritization
Provide tailored insights on priority global markets to inform Lilly’s R&D strategy
Build strong relationships with R&D leadership, therapeutic area and functional teams in order to translate insights into actionable recommendations, influence complex technical and business decisions, and enable differentiation strategies
Deliver high-impact portfolio reviews and presentations that simplify complexity and drive strategic decision-making
Lead the successful delivery of complex initiatives, while championing technical and scientific excellence, strategic insight, and a culture of collaboration and innovation
Communicate key insights and implications across governance committees and leadership forums
Qualification
Required
Four-year degree in an engineering or scientific discipline
10+ years of pharmaceutical or biotechnology industry experience with demonstrated expertise in drug discovery and/or development
Preferred
Advanced degree (PhD, PharmD, MS or the equivalent) in an engineering, scientific, health-related, or business field
Deep intellectual curiosity and a passion for advancing knowledge in cutting-edge science and technologies and emerging or novel therapeutic areas. Thrives in ambiguity and confidently navigates situations without precedent
Proven ability to evaluate technologies and platforms across diverse modalities, including oligonucleotide therapeutics and genetic medicines
In-depth experience analyzing the biotech and pharmaceutical competitive landscape across key Asian markets, particularly China
Strong strategic thinking and business acumen, including experience in discovery, drug development, business strategy, and influencing leadership decisions
Exceptional communication skills, capable of synthesizing and conveying complex technical concepts into actionable insights for diverse audiences, while representing the organization internally and externally
Demonstrated success leading high-impact initiatives and team execution while building strong relationships with global stakeholders and collaborating effectively across time zones and cultures
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase